Related Experiment Videos
Cytopathic effect of in situ gene therapy in prostate cancer
G Ayala1, T M Wheeler, M Shalev
1Department of Pathology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
This is a morphologic study of in situ gene therapy effects in patients with prostate cancer using the Herpes Simplex VirusThymidine Kinase gene (HSV-tk) followed by ganciclovir. Prostatectomy specimens from the first 4 patients showed the following morphologic changes: (1) various degrees of necrosis were seen in cancer foci; (2) cytopathic changes were seen across the whole spectrum of Gleason grades; (3) the normal prostate was rarely affected by necrosis, but contained an intense mononuclear infiltrate; (4) loss of nuclear detail was a common finding. Volumetric studies showed that only portions of the tumor show morphologic effects as well as an inverse relationship between percentage of affected tumor and prostate and tumor size. An inflammatory response was observed, with predominance of CD20-positive cells in normal prostate tissue, CD8 (cytotoxic T cells) in the tumor, and macrophages in all areas of the treated prostates. We believe that these changes represent the cytopathic effect of our in situ gene therapy on prostate cancer, and that they trigger a local immune response.
Insights
This study explored in situ gene therapy for prostate cancer using the Herpes Simplex Virus-Thymidine Kinase gene (HSV-tk) and ganciclovir. Morphologic analysis revealed tumor necrosis and an immune response, suggesting therapeutic effects.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Prostate cancer remains a significant health concern.
- In situ gene therapy offers a targeted treatment approach.
- The Herpes Simplex Virus-Thymidine Kinase (HSV-tk) gene therapy with ganciclovir is being investigated for prostate cancer.
Purpose of the Study:
- To investigate the morphologic effects of in situ HSV-tk/ganciclovir gene therapy on prostate cancer.
- To assess the relationship between gene therapy effects, tumor characteristics, and immune response.
Main Methods:
- Morphologic examination of prostatectomy specimens from patients treated with in situ gene therapy.
- Volumetric analysis to quantify treatment effects.
- Immunohistochemical staining to identify inflammatory cell populations (CD20, CD8, macrophages).
Main Results:
- Observed varying degrees of tumor necrosis and cytopathic changes across Gleason grades.
- Found that only portions of the tumor exhibited morphologic effects, with an inverse relationship to tumor size.
- Detected a localized inflammatory response with distinct immune cell profiles in tumor and normal prostate tissues.
Conclusions:
- The observed morphologic changes are consistent with the cytopathic effects of HSV-tk/ganciclovir gene therapy.
- The gene therapy appears to trigger a local immune response in prostate cancer patients.
- Further research is warranted to optimize this in situ gene therapy approach.